Belleair Asset Management LLC Invests $1.10 Million in Cardinal Health, Inc. $CAH

Belleair Asset Management LLC purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,354 shares of the company’s stock, valued at approximately $1,100,000. Cardinal Health makes up approximately 1.0% of Belleair Asset Management LLC’s holdings, making the stock its 25th biggest holding.

A number of other hedge funds have also made changes to their positions in CAH. SJS Investment Consulting Inc. boosted its holdings in Cardinal Health by 1,363.6% in the third quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares during the period. Aventura Private Wealth LLC acquired a new position in Cardinal Health in the fourth quarter worth $25,000. Jones Financial Companies Lllp boosted its holdings in Cardinal Health by 198.3% in the first quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares during the period. JPL Wealth Management LLC acquired a new position in Cardinal Health in the third quarter worth $31,000. Finally, Turning Point Benefit Group Inc. acquired a new position in Cardinal Health in the third quarter worth $31,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health News Roundup

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Raised and narrowed FY?2026 non?GAAP EPS guidance to $10.70–$10.80 (above Street consensus), signaling management confidence in specialty pharma demand. Cardinal Health lifts annual profit forecast on strong demand for specialty drugs — Reuters
• Positive Sentiment: Q3 non?GAAP EPS beat — $3.17 vs. ~$2.80 consensus — and non?GAAP operating earnings rose ~18%, showing margin improvement on pharma and specialty growth. Cardinal Health (CAH) Q3 Earnings Beat Estimates — Zacks
• Positive Sentiment: Returned capital and reduced leverage: completed an additional $250M buyback this quarter (bringing FY total to $1.0B), which supports EPS and buyback-driven shareholder returns. Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook — PR Newswire
• Neutral Sentiment: Earnings materials and call transcript are available for walk?throughs of segment dynamics (pharma vs. Med/surg, specialty drug margins) for investors who want detail. Cardinal Health, Inc. (CAH) Q3 2026 Earnings Call Transcript — Seeking Alpha
• Neutral Sentiment: Analyst activity (e.g., new coverage/positive notes) and media pieces highlight differing views — some push the stock higher on guidance; others focus on the revenue miss. Cardinal Health Rises. A Guidance Hike Powers the Stock Past These Weak Points. — Barron’s
• Negative Sentiment: Revenue missed expectations: Q3 sales ~$60.9B vs. ~$62.2B est., raising concerns about volume/price trends and muting the EPS beat. Cardinal Health is getting pummeled on mixed results — here’s our plan for stock — CNBC
• Negative Sentiment: GAAP results were weaker: GAAP operating earnings and EPS fell (GAAP EPS down ~20%) after a $184M pre?tax goodwill impairment in Navista & ION — a one?time but visible hit to GAAP profitability. Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook — PR Newswire
• Negative Sentiment: Market reaction: despite the EPS beat and guidance raise, investors sold on mixed signals (top?line miss + impairment), producing heavier volume and downward pressure. Why Is Cardinal Health Stock Sinking Thursday? — Benzinga

Cardinal Health Stock Performance

Shares of CAH opened at $193.21 on Friday. Cardinal Health, Inc. has a 1 year low of $136.71 and a 1 year high of $233.60. The company has a market cap of $45.47 billion, a price-to-earnings ratio of 27.80, a price-to-earnings-growth ratio of 1.31 and a beta of 0.64. The firm has a fifty day moving average of $213.73 and a 200-day moving average of $205.46.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.68% and a negative return on equity of 92.50%. The company had revenue of $60.94 billion during the quarter, compared to the consensus estimate of $62.10 billion. During the same quarter in the previous year, the company posted $2.35 earnings per share. The company’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Analysts predict that Cardinal Health, Inc. will post 10.32 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 15th. Investors of record on Wednesday, April 1st were paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date was Wednesday, April 1st. Cardinal Health’s payout ratio is currently 29.35%.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Citigroup raised shares of Cardinal Health from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $190.00 to $244.00 in a report on Friday, January 9th. Argus lifted their price objective on shares of Cardinal Health from $232.00 to $248.00 and gave the stock a “buy” rating in a report on Wednesday, February 11th. Jefferies Financial Group lifted their price objective on shares of Cardinal Health from $220.00 to $270.00 and gave the stock a “buy” rating in a report on Thursday, January 22nd. UBS Group set a $260.00 price objective on shares of Cardinal Health and gave the stock a “buy” rating in a report on Friday, February 6th. Finally, TD Cowen lifted their price objective on shares of Cardinal Health from $233.00 to $251.00 and gave the stock a “buy” rating in a report on Wednesday, February 11th. One research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $244.33.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.